Wednesday, 4 August 2021

New study details enzyme that allows coronavirus to resist antiviral medications

New study details enzyme that allows coronavirus to resist antiviral medications
New study details enzyme that allows coronavirus to resist antiviral medications

The coronavirus that causes COVID-19 has demonstrated a stubborn ability to resist most nucleoside antiviral treatments, but a new study led by an Iowa State University scientist could help to overcome the virus’s defenses.

admin Wed, 08/04/2021 - 16:16

source https://www.pharmatutor.org/pharma-news/2021/new-study-details-enzyme-that-allows-coronavirus-to-resist-antiviral-medications

No comments:

Post a Comment

Pharmaceutical Industry and pharma / Life Sciences institute openings 2025

  Intas Pharma Walk in Drive for M.Pharm, B.Pharm | Multiple Posts M.Pharma / B.Pharma. Injectable/Parenteral/Sterile - Aseptic, Manufacturi...